Stem Cell Agency Awards $39 Million [California]
By Los Angeles Times,
Los Angeles Times
| 09. 10. 2005
California's stem cell research agency awarded the first of a planned $3 billion in grants Friday, announcing that a little less than $39 million would go to UCLA, UC Irvine, Stanford and several other campuses to help set up programs to train scientists.
Although the amount was relatively small, competition among 26 universities and nonprofit institutions was stiff because those selected hope to be at the front of the line for more lucrative public financing to come.
The agency's Independent Citizens' Oversight Committee chose 16 winners.
The agency, the California Institute for Regenerative Medicine, was set up by Proposition 71, which voters passed last year to fund a program of research using embryonic stem cells to develop potential treatments for disease.
For now, the institute doesn't have any of its own money to give out. Lawsuits filed by anti-tax and antiabortion groups have blocked the state from issuing the bonds that Proposition 71 authorized.
As a result, the agency's chairman, Robert Klein, has been asking private philanthropic groups to fill the void with the expectation that they will be repaid...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
